Evidence map›Paper›PMID 41654714›Full record

ArticleBMC primary care2026

Proactive health behaviour intervention strategies for older T2DM patients with multimorbidity: protocol for a cluster randomised controlled trial with hybrid type 2 effectiveness-implementation design.

Yang Li, Qian Huang, Jianli Ge, Yue Liu, Shasha Geng, Qingqing Li, Xin Chen, Yingqian Zhu, Xiaotong Guo, Fengyi Lu and 4 more

Abstract readClinical Trial Protocol
In one paragraph

Article in BMC primary care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Yang Li *Department of General Practice, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.
Qian Huang *Department of General Practice, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.
Jianli GeDepartment of General Practice, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.
Yue LiuDepartment of General Practice, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.
Shasha GengDepartment of General Practice, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.
Qingqing LiDepartment of General Practice, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.
Xin ChenDepartment of General Practice, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.
Yingqian ZhuDepartment of General Practice, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.
Xiaotong GuoDepartment of General Practice, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.
Fengyi LuDepartment of General Practice, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.
Ning XuDepartment of General Practice, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.
Minggang YuDepartment of General Practice, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.
Liang ZhengResearch Center for Translational Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.
Hua JiangDepartment of General Practice, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China. huajiang2013@tongji.edu.cn.

Funding

National Key Research and Development Program of China 2022YFC3601504Special Project of Clinical Research in Health Industry of Shanghai Municipal Health Commission 202140248
6 · The paper itself

Abstract

backgroundThe increasing prevalence of multimorbidity represents a significant public health challenge, particularly in an ageing global population. This is particularly evident in patients with type 2 diabetes mellitus (T2DM), yet the management of lifestyle factors remains suboptimal. The objective of this study was to evaluate the efficacy, feasibility and cost-effectiveness of proactive health behaviour intervention strategies based on digital health technology and the multi-theory model at the primary care level.

methodsA cluster randomised controlled trial with a 24-month follow-up period will be conducted to evaluate the effectiveness of the proactive health behaviour intervention strategies. The strategies comprises three components, including free multi-sign monitoring bracelets and a mobile application, proactive health behaviour education delivered via short video format, and goal setting and support through shared decision-making. These elements can be readily integrated into routine outpatient practice. A minimum of 420 older T2DM patients with multimorbidity and exhibiting suboptimal proactive health behaviours will be recruited from 14 primary healthcare centres (PHCs) and randomly assigned on a PHC basis. The primary outcomes will be whether the participants have achieved at least one goal at six months, whether they have achieved glycemic control, and their cardiometabolic health scores at six months. The effectiveness of the intervention strategies will be assessed using the intention-to-treat dataset and mixed effect models. Additionally, implementation assessments and cost-effectiveness analyses will be conducted. Ethical approval for the protocol was obtained from the Ethics Committee of Shanghai East Hospital (No. 2024YS-083). DISCUSSION: This article presents the methodology of a pragmatic cluster randomised controlled trial utilising a hybrid effectiveness-implementation type 2 design. The objective is to assess the potential applicability of the proactive health behaviour intervention strategies in primary care for older T2DM patients with multimorbidity.

trial registrationThe study protocol has been registered prospectively in the Chinese Clinical Trial Registry (ChiCTR2400088374, assigned on 16/08/2024). Recruitment is ongoing at the time of manuscript submission.

Indexed as

Diabetes Mellitus, Type 2Health BehaviorAgedCost-Benefit AnalysisCost-Effectiveness AnalysisDigital HealthFemaleHumansMaleMultimorbidityPrimary Health CareRandomized Controlled Trials as TopicBehaviour changeMultimorbidityOlder peoplePrimary careProactive healthT2DM

Identifiers

PMID41654714
PMCPMC12977926

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.